发明名称 COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
摘要 Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited by the compounds described. For example, the chymotrypsin-like activity of the 20S proteasome may be selectively inhibited with the inventive compounds. The peptide-based compounds include an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds are expected to display anti-inflammatory properties and inhibition of cell proliferation.
申请公布号 EP3101026(A1) 申请公布日期 2016.12.07
申请号 EP20160166492 申请日期 2005.08.08
申请人 Onyx Therapeutics, Inc. 发明人 SMYTH, Mark S.;LAIDIG, Guy J.
分类号 C07K5/087;A61K38/00;A61K38/04;C07K5/04 主分类号 C07K5/087
代理机构 代理人
主权项
地址